These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines. Picazo JJ Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362 [TBL] [Abstract][Full Text] [Related]
4. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Muñoz-Almagro C; Jordan I; Gene A; Latorre C; Garcia-Garcia JJ; Pallares R Clin Infect Dis; 2008 Jan; 46(2):174-82. PubMed ID: 18171247 [TBL] [Abstract][Full Text] [Related]
5. [Streptococcus pneumoniae infection in a health district of Pamplona (Spain)]. Viguria Sánchez N; Bernaola Iturbe E; Herranz Aguirre M; Torroba Alvarez L; Gil-Setas A An Esp Pediatr; 2002 Oct; 57(4):380-1. PubMed ID: 12392678 [No Abstract] [Full Text] [Related]
6. The shifting dynamics of pneumococcal invasive disease after the introduction of the pneumococcal 7-valent conjugated vaccine: toward the new pneumococcal conjugated vaccines. Greenberg D Clin Infect Dis; 2009 Jul; 49(2):213-5. PubMed ID: 19508164 [No Abstract] [Full Text] [Related]
7. Effects of a large-scale introduction of the pneumococcal polysaccharide vaccine among elderly persons in Stockholm, Sweden. Spindler C; Hedlund J; Jasir A; Normark BH; Ortqvist A Vaccine; 2008 Oct; 26(43):5541-6. PubMed ID: 18602961 [TBL] [Abstract][Full Text] [Related]
9. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain. Benito-Fernández J; Raso SM; Pocheville-Gurutzeta I; SánchezEtxaniz J; Azcunaga-Santibañez B; Capapé-Zache S Pediatr Infect Dis J; 2007 Aug; 26(8):667-71. PubMed ID: 17848875 [TBL] [Abstract][Full Text] [Related]
10. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006. Steenhoff AP; Wood SM; Rutstein RM; Wahl A; McGowan KL; Shah SS Pediatr Infect Dis J; 2008 Oct; 27(10):886-91. PubMed ID: 18776825 [TBL] [Abstract][Full Text] [Related]
12. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Hendrickson DJ; Blumberg DA; Joad JP; Jhawar S; McDonald RJ Pediatr Infect Dis J; 2008 Nov; 27(11):1030-2. PubMed ID: 18845981 [TBL] [Abstract][Full Text] [Related]
13. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)]. Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology of invasive pneumococcal disease among adult patients in barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Ardanuy C; Tubau F; Pallares R; Calatayud L; Domínguez MA; Rolo D; Grau I; Martín R; Liñares J Clin Infect Dis; 2009 Jan; 48(1):57-64. PubMed ID: 19035779 [TBL] [Abstract][Full Text] [Related]
15. Pneumococcal vaccines in India. Dutta AK; Aggarwal A Indian J Pediatr; 2001 Mar; 68 Suppl 1():S39-43. PubMed ID: 11411384 [No Abstract] [Full Text] [Related]
17. Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect? Moore MR; Whitney CG Clin Infect Dis; 2008 Jan; 46(2):183-5. PubMed ID: 18171248 [No Abstract] [Full Text] [Related]
18. [Impact of invasive pneumococcal infection in children]. Sáez-Llorens X An Esp Pediatr; 2002 Nov; 57(5):391-3. PubMed ID: 12467540 [No Abstract] [Full Text] [Related]
19. Prevention of pneumococcal disease among adults. Maxim RB Med Health R I; 2001 May; 84(5):174-5. PubMed ID: 11392959 [No Abstract] [Full Text] [Related]